% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{BlancDurand:850240,
author = {Blanc-Durand, Paul and Van Der Gucht, Axel and Verger,
Antoine and Langen, Karl-Josef and Dunet, Vincent and Bloch,
Jocelyne and Brouland, Jean-Philippe and Nicod-Lalonde,
Marie and Schaefer, Niklaus and Prior, John O.},
title = {{V}oxel-based 18{F}-{FET} {PET} segmentation and automatic
clustering of tumor voxels: {A} significant association with
{IDH}1 mutation status and survival in patients with
gliomas},
journal = {PLoS one},
volume = {13},
number = {6},
issn = {1932-6203},
address = {Lawrence, Kan.},
publisher = {PLoS},
reportid = {FZJ-2018-04295},
pages = {e0199379 -},
year = {2018},
abstract = {IntroductionAim was to develop a full automatic clustering
approach of the time-activity curves (TAC) from dynamic
18F-FET PET and evaluate its association with IDH1 mutation
status and survival in patients with
gliomas.MethodsThirty-seven patients (mean age: 45±13 y)
with newly diagnosed gliomas and dynamic 18F-FET PET before
any histopathologic investigation or treatment were
retrospectively included. Each dynamic 18F-FET PET was
realigned to the first image and spatially normalized in the
Montreal Neurological Institute template. A tumor mask was
semi-automatically generated from Z-score maps. Each brain
tumor voxel was clustered in one of the 3 following
centroids using dynamic time warping and k-means clustering
(centroid #1: slowly increasing slope; centroid #2: rapidly
increasing followed by slowly decreasing slope; and centroid
#3: rapidly increasing followed by rapidly decreasing
slope). The percentage of each dynamic 18F-FET TAC within
tumors and other conventional 18F-FET PET parameters
(maximum and mean tumor-to-brain ratios [TBRmax and
TBRmean], time-to-peak [TTP] and slope) was compared between
wild-type and IDH1 mutant tumors. Their prognostic value was
assessed in terms of progression free-survival (PFS) and
overall survival (OS) by Kaplan-Meier
estimates.ResultsTwenty patients were IDH1 wild-type and 17
IDH1 mutant. Higher percentage of centroid #1 and centroid
#3 within tumors were positively (P = 0.016) and negatively
(P = 0.01) correlated with IDH1 mutated status. Also,
TBRmax, TBRmean, TTP, and slope discriminated significantly
between tumors with and without IDH1 mutation (P range 0.01
to 0.04). Progression occurred in 22 patients $(59\%)$ at a
median of 13.1 months (7.6–37.6 months) and 13 patients
$(35\%)$ died from tumor progression. Patients with a
percentage of centroid #1 > $90\%$ had a longer survival
compared with those with a percentage of centroid #1 <
$90\%$ (P = 0.003 for PFS and P = 0.028 for OS). This
remained significant after stratification on IDH1 mutation
status (P = 0.029 for PFS and P = 0.034 for OS). Compared to
other conventional 18F-FET PET parameters, TTP and slope
were associated with PFS and OS (P range 0.009 to
0.04).ConclusionsBased on dynamic 18F-FET PET acquisition,
we developed a full automatic clustering approach of TAC
which appears to be a valuable noninvasive diagnostic and
prognostic marker in patients with gliomas},
cin = {INM-4},
ddc = {500},
cid = {I:(DE-Juel1)INM-4-20090406},
pnm = {573 - Neuroimaging (POF3-573)},
pid = {G:(DE-HGF)POF3-573},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:29953478},
UT = {WOS:000436645400028},
doi = {10.1371/journal.pone.0199379},
url = {https://juser.fz-juelich.de/record/850240},
}